<DOC>
	<DOC>NCT00099736</DOC>
	<brief_summary>The efficacy and safety of FTY720 is being evaluated in patients who receive a kidney transplant.</brief_summary>
	<brief_title>Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant</brief_title>
	<detailed_description />
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>First kidney transplantation Male and female patients Between 18 and 65 years old Patients in need of multiple organ transplants</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Kidney, transplantation, rejection, immunosuppression</keyword>
</DOC>